| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |